BioCentury
ARTICLE | Financial News

BioBlast Pharma completes direct public offering

March 21, 2016 7:00 AM UTC

BioBlast Pharma Ltd. (NASDAQ:ORPN), Tel Aviv, Israel Business: Musculoskeletal Date completed: 2016-03-17 Type: Direct public offering Raised: $6.7 million Shares: 2.2 million Price: $3.10 Shares afte...